The European Cancer Conference (ECCO), the leading multidisciplinary oncology platform in Europe, took place in Paris from October 30 to November 3, 2005. One of the highlights was a discussion of a ...
A large, multi-institution study led by a Brown University physician-scientist could have important implications for the development of new classes of cancer therapeutics.
Dr. Takahiro Yasui (Professor, Nagoya City University) and Dr. Rei Unno (Research fellow, Nagoya City University) in collaboration with Dr. Tsuyoshi Kawabata (Associate Professor, Nagasaki University) ...
Interrupting one function of a protein that plays a key role in cell signaling could enable the development of new cancer treatments, according to a study led by Dr. Martin Taylor at the Warren Alpert ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback